Multidrug resistance over expression(MDR1)

Occurs less frequently in young patients with acute myelogenous leukemia.

Older patients with acute myelogenous leukemia have a high rate of MDR1, 71%,.

Increased expression in AML in patients with favorable or intermediate cytogenetics have a decreased complete remission rates and, in some studies, poorer survival.

Leave a Reply

Your email address will not be published. Required fields are marked *